Pharmacology & Toxicology Poster Session
| INABIS '98 Home Page | Your Session | Symposia & Poster Sessions | Plenary Sessions | Exhibitors' Foyer | Personal Itinerary | New Search |
Results
PATIENTS FEATURES
Patients
n |
% |
|
| GENDER | ||
Female |
407 |
54.3 |
Male |
342 |
45.7 |
| AGE GROUPS | ||
1-4 |
48 |
6.4 |
5-14 |
157 |
21 |
15-29 |
189 |
25.2 |
Over 30 |
355 |
47.4 |
PATIENTS CLASSIFICATION ATTENDING DEGREE OF DISEASE
n |
% |
|
Mild |
224 |
30 |
Moderate |
131 |
17.4 |
Severe |
142 |
19 |
No classified |
201 |
26.8 |
No records |
51 |
6.8 |
Definitions of disease degrees
Mild: < 6 crisis per year
Moderate: 6 to 9 crises per year
Severe: 10 or more crises per year
Not classified: not enclosed in previous categories
No record: no clinical record was found.
EXTENT OF DISEASE CONTROL
Asthmatic crises |
Patients |
N % |
|
Yes |
557 74 |
No |
192 96 |
Wards admission |
|
Yes |
84 11 |
No |
665 89 |
INFORMATION SOURCES ABOUT TREATMENT
| N | % | |
| PRESCRIBED in CLINICAL RECORD | ||
| Yes | 299 | 39.9 |
| No | 399 | 53.2 |
| No clinical record | 51 | 6.8 |
| REFERRED by PATIENT | ||
| Yes | 646 | 86.3 |
| No | 103 | 13.7 |
PHARMACOLOGICAL GROUPS USED TO TREAT SYMPTOMS
| Prescribed in Clinical Record | Referred by Patients | |||
N |
% |
n |
% |
|
| BRONCHODILATORS | ||||
|
150 | 45.6 | 483 | 54.7 |
|
110 | 31.6 | 195 | 22.1 |
Antihistamines H1 |
17 | 4.9 | 40 | 4.5 |
Sodium cromoglicate |
2 | 0.6 | 6 | 0.6 |
Corticoids |
9 | 2.6 | 54 | 6.1 |
Fixed Drug Combinations |
45 | 13 | 75 | 8.5 |
Other |
6 | 1.7 | 30 | 3.4 |
Results by number of drugs (%) |
||||
PHARMACOLOGICAL GROUPS for PROPHYLAXIS
| Prescribed in Clinical Record | Referred by Patients | |||
| n | % | N | % | |
| Bronchodilators | ||||
| b 2 agonists | 20 | 14.5 | 40 | 11.3 |
| Xantines | 9 | 6.7 | 20 | 5.6 |
| Antihistamines H1 | 57 | 41.6 | 178 | 50.1 |
| Sodium Cromoglicate | 29 | 21.2 | 58 | 16.3 |
| Corticoids * | 12 | 8.7 | 26 | 7.3 |
| Fixed drugs Combinations | 4 | 3.0 | 16 | 4.5 |
| Other | 6 | 4.3 | 17 | 5.0 |
| Results by number of drugs (%) | ||||
* In Cuba there are not inhaled corticoids registered.
INHALED b 2 AGONIST FOR SYMPTOMATIC TREATMENT ACCORDING WITH DISEASE DEGREE
#Times inhaled |
MILD | MODERATE | SEVERE |
NO Classified |
No clinical record |
TOTAL |
||||||
| n | % |
n |
% |
n |
% |
n |
% |
n |
% |
n |
% |
|
1 |
24 |
57.1 |
6 |
14.3 |
1 |
2.4 |
11 |
26.2 |
42 |
100 |
||
2 – 8 |
72 |
28.3 |
57 |
22.4 |
58 |
22.8 |
52 |
20.5 |
15 |
6 |
254 |
100 |
More than 8 |
5 |
29.4 |
1 |
5.9 |
7 |
41.2 |
4 |
23.5 |
17 |
100 |
||
As needed |
27 |
18.4 |
21 |
14.3 |
49 |
33.3 |
36 |
24.5 |
14 |
9.5 |
147 |
100 |
Results by number of patients (%) |
||||||||||||
| <= Materials & Methods | RESULTS | Discussion & Conclussions => |
| Discussion Board | Next Page | Your Poster Session |